NOTE: At the time of this manuscript publication an Investigational New Drug (IND) application is not required to perform an FMT for recurrent CDI in clinical practice. However, if FMTs are being performed as part of a study or for another indication, an IND or equivalent application may be required18 . Regulatory agencies will likely continue to assess the safety and efficacy of FMT as applied to CDI and other medical conditions and so it is advised to check the regulatory requirements in your respective location prior to the initiation of an FMT program and every one to two months once actively performing FMT.
NOTE Candidates must be willing to consent to the fecal transplant as well as the colonoscopy.
1. Identification of Appropriate Candidates for FMT
2. Stool Donor Selection
NOTE: Stool Donor selection applies to the treatment of CDI and may not be applicable to the treatment of other disorders.
3. Donor Eligibility
4. Screening
NOTE: This screening protocol was adapted for the patients at Brigham and Women’s Hospital in Massachusetts, U.S.A. Consider consulting the infectious disease department and hospital infection control prior to initiating the FMT protocol to make sure all appropriate screening tests have been considered.
5. Pre-procedure Preparation
6. Stool Preparation
NOTE: Ensure this procedure is discussed and approved by the hospital’s infection control department.
7. Fecal Transplant via Colonoscopy
8. Colonoscopy with FMT Clean Up
9. Follow Up
10. Reporting of Adverse Events
We have performed 24 FMTs on 22 patients at our Center (Table 1) using the above protocol. Nine patients had concurrent IBD (six with Crohn’s disease and three with ulcerative colitis). All nine had resolution of CDI. One of the patients with Crohn’s disease was status post a total colectomy for Crohn’s colitis. He initially underwent FMT via colonoscopy however after experiencing a recurrence two weeks post FMT he underwent a second FMT via upper endoscopy which resulted in CDI resolution. Eleven out of thirteen of the non-IBD patients had complete resolution of symptoms related to C. difficile after one FMT with an average length of follow up of 3 months [2 weeks – 17 months]. One patient underwent a second FMT, which resulted in resolution of CDI. The second patient who relapsed after FMT opted to not have a second transplant. There were no complications related to the procedure or the FMT (i.e. infections, flare of IBD, nausea, vomiting, abdominal pain, or GI bleeding) during the limited to date follow up. One patient with IBD did experience self limited abdominal pain one day post-FMT.
Table 1: Characteristics of Patients who Underwent Fecal Microbiota Transplantation at our Center.
Please click here to view a larger version of this table.
Name of Material/ Equipment | Company | Catalog Number | Comments/Description |
Blender | Hamilton Beach | http://www.amazon.com/Hamilton-Beach-51101-Personal-Blender/dp/B00065L6CU/ref=pd_sim_k_2?ie=UTF8&refRID=1Q06MXAE9XKTB4QG0AEN | |
Strainer | Winco MS3A-8S Strainer | http://www.amazon.com/Winco-MS3A-8S-Strainer-Single-Wooden/dp/B001VZ5E40/ref=sr_1_3?s=home-garden&ie=UTF8&qid=1395001295&sr=1-3&keywords=kitchen+strainer+wooden+handle | |
Disposable pads (chux), 17in x 24in. | hospital standard | one package | |
Pink rectangular hospital standard wash basin, 8 quart | hospital standard | 1 or 2 | |
500 cc bottle of sterile normal saline | hospital standard | 2 | |
60cc leur lock syringes | hospital standard | 8 or 9 | |
Biopsy channel cap with extension | hospital standard |
Fecal Microbiota Transplantation (FMT) is a safe and highly effective treatment for recurrent and refractory C. difficile infection (CDI). Various methods of FMT administration have been reported in the literature including nasogastric tube, upper endoscopy, enema and colonoscopy. FMT via colonoscopy yields excellent cure rates and is also well tolerated. We have found that patients find this an acceptable and tolerable mode of delivery. At our Center, we have initiated a fecal transplant program for patients with recurrent or refractory CDI. We have developed a protocol using an iterative process of revision and have performed 24 fecal transplants on 22 patients with success rates comparable to the current published literature. A systematic approach to patient and donor screening, preparation of stool, and delivery of the stool maximizes therapeutic success. Here we detail each step of the FMT protocol that can be carried out at any endoscopy center with a high degree of safety and success.
Fecal Microbiota Transplantation (FMT) is a safe and highly effective treatment for recurrent and refractory C. difficile infection (CDI). Various methods of FMT administration have been reported in the literature including nasogastric tube, upper endoscopy, enema and colonoscopy. FMT via colonoscopy yields excellent cure rates and is also well tolerated. We have found that patients find this an acceptable and tolerable mode of delivery. At our Center, we have initiated a fecal transplant program for patients with recurrent or refractory CDI. We have developed a protocol using an iterative process of revision and have performed 24 fecal transplants on 22 patients with success rates comparable to the current published literature. A systematic approach to patient and donor screening, preparation of stool, and delivery of the stool maximizes therapeutic success. Here we detail each step of the FMT protocol that can be carried out at any endoscopy center with a high degree of safety and success.
Fecal Microbiota Transplantation (FMT) is a safe and highly effective treatment for recurrent and refractory C. difficile infection (CDI). Various methods of FMT administration have been reported in the literature including nasogastric tube, upper endoscopy, enema and colonoscopy. FMT via colonoscopy yields excellent cure rates and is also well tolerated. We have found that patients find this an acceptable and tolerable mode of delivery. At our Center, we have initiated a fecal transplant program for patients with recurrent or refractory CDI. We have developed a protocol using an iterative process of revision and have performed 24 fecal transplants on 22 patients with success rates comparable to the current published literature. A systematic approach to patient and donor screening, preparation of stool, and delivery of the stool maximizes therapeutic success. Here we detail each step of the FMT protocol that can be carried out at any endoscopy center with a high degree of safety and success.